Northwestern University Lead Academic Participating Site
Northwestern University Lead Academic Participating Site
批准号:
10357915
负责人:
AL B BENSON
金额:
$51.52万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2025-02-28
关键词:
AdultAdvanced Malignant NeoplasmAdvisory CommitteesAmerican College of Radiology Imaging NetworkAncillary StudyBasic ScienceCancer CenterCancer InterventionCancer PatientClinicalClinical ResearchClinical TrialsCollaborationsComprehensive Cancer CenterCore FacilityCore GrantDevelopmentDisciplineDiseaseEastern Cooperative Oncology GroupEnrollmentEnsureFacultyFinancial SupportGoalsHealthHomeInfrastructureInstitutionInternationalIntervention StudiesIntervention TrialLaboratoriesLeadLeadershipMalignant NeoplasmsMentorsMentorshipOrganization administrative structuresOutcomeOutcome MeasurePathologyPatient imagingPatientsPhasePopulation SciencesPublicationsRare DiseasesRecording of previous eventsReportingResearchResearch InfrastructureResearch PersonnelResource SharingResourcesRoleScienceScientific Advances and AccomplishmentsSiteSouthwest Oncology GroupSpecial PopulationStructureTimeTissue BanksTissuesUniversitiesValidationbasebench-to-bedside translationcancer therapycareerclinical careclinical imagingdata qualitydata repositorydesignexperiencefollow-upimage archival systemimaging modalityimprovedinter-institutionalmedical schoolsmembermultimodalityprogramsquantitative imagingranpirnaserecruitsenior facultystandard of caresuccesstissue resource
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (LCC) has a long
history of NCTN participation with ECOG membership since 1973. Currently, the LCC
infrastructure supports participation in clinical trials and ancillary studies through the ECOG-
ACRIN, SWOG, Alliance, NRG and COG. Recognized for accrual, participation, and high-level
of data quality, the LCC has been selected by the NCTN leadership to participate in the High
Performing Site Initiative (HPSI) in 2015, 2016 and 2017 to support our infrastructure and to
enable continued participation in NCTN trials. The Lurie Cancer Center's overall accrual to NCTN
studies during 3/1/14 - 8/31/17 was 400, 383 of which were accrued to Interventional trials.
In addition, LCC members are heavily involved in the leadership of NCTN activities. From 3/1/14
and 8/31/16, LCC members have served as Network Group committee and subcommittee
members (74), committee and subcommittee chairs and co-chairs (19), study chairs and co-chairs
(22), and members of various NCI Steering Committees or Task Forces (10). In addition, the
extensive number of Network Group publications (65) and abstracts (70) authored or co-authored
by the investigators during the last 3 years alone further demonstrates our leadership role within
the NCTN.
Through demonstration of significant scientific accomplishments and new initiatives, recent
recruitment of accomplished senior faculty and productive junior faculty, comprehensive and
integrated infrastructure for oversight of cancer-related clinical trials including the establishment
of a NCTN Oversight Committee, emphasis on mentoring of junior faculty, significant financial
support of NCTN activities and a highly experienced and productive leadership which has been
continuously active within the NCTN, the LCC has proved that it has the governance,
organizational capabilities and commitment, as well as the general expertise of the senior
leadership team to support this LAPS application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making
-
批准号:10797946
-
项目类别:
-
资助金额:$222.45万
-
财政年份:2023
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site, GY4 Supplemental Request
-
批准号:10736415
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site
-
批准号:10583453
-
项目类别:
-
资助金额:$77.52万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site
-
批准号:9901493
-
项目类别:
-
资助金额:$51.52万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site Supplement Year 2
-
批准号:10299729
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site
-
批准号:10062109
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORS
-
批准号:7604237
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:AL B BENSON
-
依托单位:
NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORS
-
批准号:7200422
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2004
-
负责人:AL B BENSON
-
依托单位:
NU 98X3: Irinotecan (CPT-11) and Gemcitabine in Patients with Solid Tumors
-
批准号:7040344
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2003
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6396860
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6395751
-
项目类别:
-
资助金额:$0.13万
-
财政年份:1999
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6269629
-
项目类别:
-
资助金额:$14.0万
-
财政年份:1998
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6102938
-
项目类别:
-
资助金额:$0.13万
-
财政年份:1998
-
负责人:AL B BENSON
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10902202
-
项目类别:
-
资助金额:$17.2万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10228213
-
项目类别:
-
资助金额:$23.44万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10460220
-
项目类别:
-
资助金额:$23.44万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6237432
-
项目类别:
-
资助金额:$13.33万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
THYMIDYLATE SYNTHASE EXPRESSION IN COLORECTAL CANCER
-
批准号:2110756
-
项目类别:
-
资助金额:$15.34万
-
财政年份:1995
-
负责人:AL B BENSON
-
依托单位:
THYMIDYLATE SYNTHASE EXPRESSION IN COLORECTAL CANCER
-
批准号:2110757
-
项目类别:
-
资助金额:$15.74万
-
财政年份:1995
-
负责人:AL B BENSON
-
依托单位:
PHASE I AND PHARMACOKINETIC STUDIES OF OLTIPRAZ
-
批准号:3622066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1989
-
负责人:AL B BENSON
-
依托单位: